FeesSafety
Pluang+

WEG shares dip on mixed Q3 but offer 18% upside with new factories and energy projects ahead

Company Fundamentals
24 Oct 2026
Seeking Alpha
View Source
Bullish
WEG shares dip on mixed Q3 but offer 18% upside with new factories and energy projects ahead

WEG reported mixed Q3 results with 5.7% revenue growth but margin pressure from higher copper costs, tariffs, and personnel expenses. Despite this, new transmission and distribution factories in Mexico and Colombia set to open in early 2027, plus a 4 GWh energy storage plant planned for late 2027, provide growth catalysts. The stock trades at a lower P/E of 25x compared to its 29.5x average, suggesting an 18% upside as margins and valuations improve with operational ramp-up. The market reaction to the Q3 results may present a buying opportunity for investors.

For readers following WEG Q3 results, here is Pluang's Industrials sector market snapshot as of Oct 24, 2026 15:01 WIB: Out of 135 priced stocks, 52 rose and 81 fell. Notable movers include QXO at USD 10.51 with a 1-day change of -4.63%, SMX at USD 1.75 with 98% sell order activity, and NAT at USD 7.86 with 100% buy order activity and a 4.24% gain.

More News

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
58 minutes ago
Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Darolutamide with ADT and radiation cuts metastasis or death risk by 58% in high-risk prostate cancer patients.

Interim results from the Phase 3 DASL-HiCaP trial show that adding darolutamide to standard androgen deprivation therapy (ADT) and radiation therapy reduces the risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence...

Company Fundamentals
Bullish
3 hours ago
Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic's revenue jumps to $16.3B in H1 2026, up from $1.1B last year

Anthropic reported a massive increase in revenue, reaching $16.3 billion in the first half of 2026 compared to just $1.1 billion in the same period last year. This surge highlights rapid growth and strong demand for its products or services. The dram...

Market News
Bullish
4 hours ago
NEAR Protocol leads crypto losses with an 8.93% drop amid broader market declines

NEAR Protocol leads crypto losses with an 8.93% drop amid broader market declines

NEAR Protocol (NEAR) experienced the largest 24-hour decline among major cryptocurrencies, falling 8.93% to $4.47. Other notable drops included Bitcoin down 1.28% to $80,495, Ether down 1.38% to $2,360.57, and XRP down 3.45% to $1.28. These declines ...

Market News
Bearish
4 hours ago
XRP's 2017-18 rally gains estimated between 62,000% and 119,000%, varying by measurement methods.

XRP's 2017-18 rally gains estimated between 62,000% and 119,000%, varying by measurement methods.

Estimates of XRP's price rally during 2017-18 vary widely, from about 62,000% to 119,000%, depending on different starting prices and measurement periods. Vandell Aljarrah of Black Swan Capitalist highlighted a 630-fold rise when XRP moved above a tr...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App